CRISPR-Cas Systems in the Fight Against Antimicrobial Resistance: Current Status, Potentials, and Future Directions
Mohamed Mustaf Ahmed(SIMAD University), Don Eliseo Lucero‐Prisno(University of Makati), Olaniyi Abideen Adigun(Nigerian Defence Academy), Hakeem Kayode Hassan(Bowen University Teaching Hospital), Zeinab A. Mohamed(SIMAD University), Gilbert Eshun(Unknown), Jerico Bautista Ogaya(University of Makati), Marina Ramzy Mourid(Alexandria University), Bonaventure Michael Ukoaka(Unknown), Olalekan John Okesanya(University of Thessaly)
Cited by 55
Related Papers
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
|Cancers|2022|303
Updated epidemiology of gastrointestinal cancers in East Asia
|Nature Reviews Gastroenterology & Hepatology|2023|258
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
|The Lancet Haematology|2022|208
Impact of COVID‐19 on access to healthcare in low‐ and middle‐income countries: Current evidence and future recommendations
|The International Journal of Health Planning and Management|2020|172
The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries
|Tropical Medicine and Health|2021|153